Nuvation Historical Balance Sheet
| NUVB Stock | USD 2.89 0.09 3.21% |
Trend analysis of Nuvation Bio balance sheet accounts such as Total Current Assets of 439.4 M provides information on Nuvation Bio's total assets, liabilities, and equity, which is the actual value of Nuvation Bio to its prevalent stockholders. By breaking down trends over time using Nuvation Bio balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
Financial Statement Analysis is much more than just reviewing and examining Nuvation Bio latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Nuvation Bio is a good buy for the upcoming year.
Nuvation Bio Inventory |
|
Nuvation |
About Nuvation Balance Sheet Analysis
Balance Sheet is a snapshot of the financial position of Nuvation Bio at a specified time, usually calculated after every quarter, six months, or one year. Nuvation Bio Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Nuvation Bio and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Nuvation currently owns. An asset can also be divided into two categories, current and non-current.
Nuvation Bio Balance Sheet Chart
Add Fundamental
Total Current Liabilities
Total Current Liabilities is an item on Nuvation Bio balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Nuvation Bio are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Accounts Payable
An accounting item on the balance sheet that represents Nuvation Bio obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Nuvation Bio are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.Total Current Assets
The total value of all assets that are expected to be converted into cash within one year or during the normal operating cycle.Total Assets
Total assets refers to the total amount of Nuvation Bio assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Nuvation Bio books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Total Liab
The total amount of all liabilities that a company has, including both short-term and long-term liabilities.Most accounts from Nuvation Bio's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Nuvation Bio current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nuvation Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. For information on how to trade Nuvation Stock refer to our How to Trade Nuvation Stock guide.At present, Nuvation Bio's Net Tangible Assets are projected to increase significantly based on the last few years of reporting. The current year's Accounts Payable is expected to grow to about 2.3 M, whereas Total Current Liabilities is forecasted to decline to about 10 M.
| 2021 | 2022 | 2023 | 2024 (projected) | Total Current Assets | 772.1M | 667.3M | 616.4M | 439.4M | Accounts Payable | 3.9M | 2.1M | 2.2M | 2.3M |
Nuvation Bio balance sheet Correlations
Click cells to compare fundamentals
Nuvation Bio Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Nuvation Bio balance sheet Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Total Current Liabilities | 3.2M | 6.6M | 16.9M | 13.2M | 14.0M | 10.0M | |
| Net Tangible Assets | (24.1M) | (52.4M) | 746.0M | 655.1M | 753.3M | 791.0M | |
| Retained Earnings | (34.3M) | (76.0M) | (162.8M) | (267.0M) | (342.8M) | (325.7M) | |
| Accounts Payable | 2.0M | 2.2M | 3.9M | 2.1M | 2.2M | 2.3M | |
| Total Current Assets | 119.9M | 220.7M | 772.1M | 667.3M | 616.4M | 439.4M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Nuvation Bio offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Nuvation Bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Nuvation Bio Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Nuvation Bio Stock:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nuvation Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. For information on how to trade Nuvation Stock refer to our How to Trade Nuvation Stock guide.You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nuvation Bio. If investors know Nuvation will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nuvation Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.18) | Revenue Per Share 0.009 | Return On Assets (0.14) | Return On Equity (0.96) |
The market value of Nuvation Bio is measured differently than its book value, which is the value of Nuvation that is recorded on the company's balance sheet. Investors also form their own opinion of Nuvation Bio's value that differs from its market value or its book value, called intrinsic value, which is Nuvation Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nuvation Bio's market value can be influenced by many factors that don't directly affect Nuvation Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nuvation Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nuvation Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nuvation Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.